Roy D. Baynes
Director at Natera, Inc. (NTRA); Director at Travere Therapeutics, Inc. (TVTX)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $5.4M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Jun 16SEC | TVTXTravere Therapeutics, Inc. | Sell Plan | 4,50041,500 held (−10%) | $50.00 | $225K | +4.2% |
| May 6SEC | TVTXTravere Therapeutics, Inc. | Sell Plan | 4,50037,500 held (−11%) | $46.65 | $210K | +11.7% |
| May 4SEC | TVTXTravere Therapeutics, Inc. | Sell Plan | 9,75037,500 held (−21%) | $44.22 | $431K | +17.9% |
| Apr 16SEC | TVTXTravere Therapeutics, Inc. | Sell Plan | 26,00044,250 held (−37%) | $41.07 | $1.1M | +26.9% |
| Apr 16SEC | TVTXTravere Therapeutics, Inc. | Sell Plan | 6,75037,500 held (−15%) | $42.12 | $284K | +23.8% |
| Apr 7SEC | TVTXTravere Therapeutics, Inc. | Sell Plan | 10,00037,500 held (−21%) | $33.00 | $330K | +58.0% |
| Nov 21SEC | NTRANatera, Inc. | Sell Plan | 1,25022,221 held (−5%) | $213.47 | $267K | +87.7% |
| Nov 21SEC | NTRANatera, Inc. | Sell Plan | 1,72720,494 held (−8%) | $214.79 | $371K | +86.6% |
| Nov 21SEC | NTRANatera, Inc. | Sell Plan | 2,13518,359 held (−10%) | $216.07 | $461K | +85.5% |
| Nov 21SEC | NTRANatera, Inc. | Sell Plan | 1,18424,843 held (−5%) | $220.14 | $261K | +82.0% |
| Nov 21SEC | NTRANatera, Inc. | Sell Plan | 90023,943 held (−4%) | $221.81 | $200K | +80.7% |
| Nov 21SEC | NTRANatera, Inc. | Sell Plan | 1,80022,143 held (−8%) | $222.90 | $401K | +79.8% |
| Nov 21SEC | NTRANatera, Inc. | Sell Plan | 1,90020,243 held (−9%) | $223.90 | $425K | +79.0% |
| Nov 21SEC | NTRANatera, Inc. | Sell Plan | 1,88418,359 held (−9%) | $224.89 | $424K | +78.2% |
- Sell
Director Roy D. Baynes sold $225K of TVTX at $50.00 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Roy D. Baynes sold $210K of TVTX at $46.65 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Roy D. Baynes sold $431K of TVTX at $44.22 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Roy D. Baynes sold $1.1M of TVTX at $41.07 — cuts the stake by 37%; pre-scheduled 10b5-1 plan sale.
- Sell
Director Roy D. Baynes sold $284K of TVTX at $42.12 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Roy D. Baynes sold $330K of TVTX at $33.00 — pre-scheduled 10b5-1 plan sale.